1. The V-QUIN MDR TRIAL: a randomized controlled trial of six months of daily levofloxacin for the prevention of tuberculosis among household contacts of patients with multi-drug resistant tuberculosis;ANZCT Registry – Identifier ACTRN12616000215426,2016
2. Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009–2012;Bamrah;Int J Tuberc Lung Dis,2014
3. Resistance at no cost: the transmissibility and potential for disease progression of drug-resistant M. tuberculosis;Becerra;bioRxiv,2018
4. Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients (PHOENIx MDR-TB);ClinicalTrials.gov Identifier: NCT03568383,2018
5. Eurepean Centre for Disease Prevention and Control (ECDC). Public health guidance on management of contacts of MDR TB and XDR TB patients, 2012. [cited 2018 Dec 28] Available from: http:ecdc.europa.eu/en/publications-data/public-health-guidance-management-contacts-mdr-tb-and-xdr-tb-patients